Hellerup, Denmark

Claus Bornæs

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Claus Bornæs

Introduction

Claus Bornæs is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of glucocerebrosidase associated disorders. His innovative work has led to the development of a unique active pharmaceutical ingredient.

Latest Patents

Claus Bornæs holds a patent for Arimoclomol, which is an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the acid addition salts thereof. This invention is aimed at treating glucocerebrosidase associated disorders, showcasing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Claus has worked with several prominent companies, including Orphazyme A/S and Zevra Denmark A/S. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Claus has collaborated with notable professionals in his field, including Anders Mørkeberg Hinsby and Thomas Kirkegaard Jensen. These partnerships have further enhanced his innovative capabilities and have led to significant advancements in his research.

Conclusion

Claus Bornæs is a distinguished inventor whose work in pharmaceuticals has made a lasting impact on the treatment of glucocerebrosidase associated disorders. His innovative spirit and dedication to research continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…